Clinical review demonstrates high tumor control with low morbidity from stereotactic radiosurgery in vestibular schwannoma, supporting size-stratified treatment strategies.
Vestibular schwannoma (VS) is the most common lesion of the cerebellopontine angle, accounting for approximately 8–10% of all intracranial tumors. Current treatment options include microsurgery, stereotactic radiosurgery (SRS), and conservative observation. SRS has been established as a primary treatment option and a viable alternative to microsurgery, offering high tumor control rates with low morbidity. This review summarizes current discussions regarding SRS for VS, based on recent studies and international guidelines. It also provides evidence-based treatment strategies according to tumor size to inform clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: